Study shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetes
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience...
At a Glance Researchers found that infectious bacteria in diabetic mice rapidly evolved resistance to antibiotics. Controlling blood sugar in...
This situation is exemplified by the low compliance with postpartum glucose screening among women who had gestational diabetes—a condition that...
SettingTrainings occurred at two nonprofit community clinics in Houston, Texas. Each site hosted a separate training, totaling two trainings. The...
Glucagon-like peptide-1 (GLP-1) receptor agonists were not associated with an increased risk of suicide compared to dipeptidyl peptidase-4 (DPP-4) or...
The global incidence and prevalence of diabetes continue to rise, increasing rates of associated disability and mortality while imposing a...